SAN ANTONIO (June 9, 2015) – Cancer survivors and healthcare providers are invited to explore diet, intimacy, spirituality, and more at the Women’s Survivorship Summit from 8 a.m. to 1 p.m. Saturday, June 13, 2015, at the Whitley Center at the Oblate School of Theology.
Register here for the summit, which will feature free food, speakers, and cancer resources.
“Having faced down cancer, survivors now face new challenges, both clinical and psychological,” said Virginia Kaklamani, M.D., director of the breast oncology program at the UT Health Science Center’s Cancer Therapy & Research Center. “I’ll be talking about both types of consequences, and how women can tackle them.”
Other experts will cover topics such as healing foods and the impact of cancer on survivors’ mental health, personal relationships, spirituality and culture.
“We’re excited to showcase relevant topics and resources that can really improve the quality of life of cancer survivors,” said Sandra San Miguel, summit co-chair and a researcher for Redes En Acción, a Latino cancer research network supported by the National Cancer Institute and led by the Institute for Health Promotion Research at the UT Health Science Center.
The summit, sponsored by the Alamo Breast Cancer Foundation (ABCF) and AstraZeneca, is the first event organized by the San Antonio Breast Cancer Collaborative, a coalition of groups developed by the ABCF to promote local cancer services and public education.
The collaborative includes the UT Health Science Center, CTRC, the Breast Friends Forever Young Survivors support group led by San Miguel, Alamo City Cancer Council, National Inter-Organizational Collaborative (Indian and Asian Community), SLEW Wellness Center, Baptist Breast Center, the San Antonio affiliates of Susan G. Komen, American Cancer Society, and YWCA USA, and others.
The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio is one of the elite academic cancer centers in the country to be named a National Cancer Institute (NCI) Designated Cancer Center, and is one of only four in Texas. A leader in developing new drugs to treat cancer, the CTRC Institute for Drug Development (IDD) conducts one of the largest oncology Phase I clinical drug programs in the world, and participates in development of cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit www.ctrc.net.